Stay updated on Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page
- Check2 days agoChange DetectedStudy status updated to Suspended Per PI with cohorts closed for analysis. Enrollment is affected and ongoing access to study information may be limited.SummaryDifference0.4%

- Check9 days agoNo Change Detected
- Check31 days agoChange DetectedUpdated operating-status notice and versioning: added a current funding/status banner and new date/revision (v3.2.0), while removing older date references and the previous revision (v3.1.0).SummaryDifference4%

- Check38 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check52 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check66 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location related to Thyroid Cancer, while several specific terms and resources related to cancer treatment have been removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Chemo-Resistant Tumors Clinical Trial page.